ROYAL BANK OF CANADA
BankPosition in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1000275
TORONTO, A6
Position in REGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$108,817,078
-$162,511,678 QoQ
Shares Held
174,515
-50.3% QoQ
Ownership
0.170%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#77
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Derivatives in REGN
reported options exposure · as of Mar 31, 2026CallValue
$13,598,464
CallShares
17,600
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026ROYAL BANK OF CANADA holds $2,116,200,383 across 427 Biotechnology names. REGN ranks #5 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
6,182,479 | $490,208,754 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
980,259 | $486,924,048 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
875,859 | $263,659,830 | |
| 4 | INCY |
Incyte Corp
|
1,132,050 | $128,329,182 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
174,515 | $108,817,078 | |
| 6 | MRNA |
Moderna, Inc.
|
944,457 | $66,140,319 | |
| 7 | INSM |
INSMED Inc
|
416,487 | $44,405,840 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
545,761 | $42,716,712 |
All Filings in REGN
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $108,817,078 | 174,515 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $13,598,464 | 17,600 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $271,328,756 | 351,171 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $266,464,185 | 345,219 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $209,780,120 | 373,095 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $202,061,475 | 384,879 | Shares | Defined | 2025-11-21 | |
| 2025-03-31 | $128,873,628 | 203,197 | Shares | Defined | 2025-11-21 | |
| 2024-12-31 | $205,818,489 | 288,937 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $274,836,181 | 261,440 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $209,098,210 | 198,946 | Shares | Defined | 2024-11-06 | |
| 2024-03-31 | $133,356,834 | 138,554 | Shares | Defined | 2024-11-05 | |
| 2024-03-31 | $192,498 | 200 | Put | Defined | 2024-11-05 | |
| 2023-12-31 | $229,928,411 | 261,791 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $131,618,457 | 159,933 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $109,894,941 | 152,942 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $148,578,473 | 180,825 | Shares | Defined | 2023-05-15 | |
| 2023-03-31 | $4,519,185 | 5,500 | Put | Sole | 2023-05-15 | |
| 2022-12-31 | $215,042,976 | 298,054 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $222,883,195 | 323,549 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $198,987,949 | 336,623 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $219,550,416 | 314,353 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $175,637,704 | 278,119 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $119,194,434 | 196,957 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $56,318,141 | 100,831 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $48,239,457 | 101,956 | Shares | Defined | 2021-07-20 | |
| 2020-12-31 | $79,872,571 | 165,330 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $67,521,779 | 120,622 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $67,483,291 | 108,207 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $40,208,235 | 82,345 | Shares | Defined | 2020-06-16 | |
| No filing history on record for this holder in this stock. | ||||||